Doctor Jonas Silverdal

Sahlgrenska University Hospital, Gothenburg (Sweden)

Membership: ESC Professional Member

Contributor content

Presentation

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

Presentation

Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study

$Mortality and prognostic factors in dilated cardiomyopathy versus ischaemic heart disease in patients with heart failure with reduced ejection fraction - a Swedish population-based study$

Presentation

Mortality and prognostic factors in dilated cardiomyopathy versus ischaemic heart disease in patients with heart failure with reduced ejection fraction - a Swedish population-based study

Presentation

Prognostic impact of ischemic heart disease in heart failure, and its trend over time

Explore sponsored resources

Doctor Jonas Silverdal

Contributor content

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study

Mortality and prognostic factors in dilated cardiomyopathy versus ischaemic heart disease in patients with heart failure with reduced ejection fraction - a Swedish population-based study

Prognostic impact of ischemic heart disease in heart failure, and its trend over time

ESC 365 is supported by